Last updated: 2026-09-16 10:32:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Treace Medical Concepts, Inc. (TMCI) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $4,59, with a market capitalisation of $301,11M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,17 to $7,61. This page covers its latest market performance, valuation, price trends and company information.
$301,11M | |
$4,59 | |
$37,17 | |
$1,17 | |
$4,58 | |
276,00 | |
586,54K | |
-- | |
$7,61 | |
$1,17 | |
-- | |
-- |
Treace Medical Concepts, Inc. (TMCI) is trading at $4,59 in pre-market trading as of 2026-09-16 10:16:00, up 0,11% ($0,00) from the previous close of $4,58
Pre-market trading shows how investors are pricing TMCI before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Treace Medical Concepts, Inc. (TMCI) moved from $4,81 to $4,59, representing a decline of 4,68% ($0,22).
The stock traded between $4,31 and $4,89 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 196,59 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 53,0%
TMCI is currently trading at $4,59, placing it 53,0% of the way from its 52-week low of $1,17 to its 52-week high of $7,61. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 450 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Treace Medical Concepts, Inc. (TMCI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.